Table 1.
Socio-demographic and clinical characteristics of study sample
|
Characteristics |
UK Sample (N=144) |
US sample (N=137) |
|
|---|---|---|---|
| Mean (STD) or N (%) | p* | ||
|
CKD stage |
|
|
<0.01 |
| CKD stage 1-2 |
24 (16.8) |
51 (37.5) |
|
| CKD stage 3 |
65 (45.5) |
50 (36.8) |
|
| CKD stage 4 |
37 (25.9) |
26 ( 19.1) |
|
| CKD stage 5 |
17 * (11.9) |
9 (6.6) |
|
|
Women |
56 (39.2) |
46 (33.3) |
0.35 |
|
Age |
52.0 (13.8) |
49.1 (12.9) |
0.07 |
|
Months since Transplant |
63.7 (40.9) |
39.5 (52.8) |
<0.01 |
|
Diabetes |
26 (18.2) |
46 (33.3) |
<0.01 |
|
Cardiovascular Disease (CVD) |
44 (30.1) |
31 (22.6) |
0.13 |
|
Hypertension (HTN) |
82 (57.3) |
40 (29.2) |
<0.01 |
|
Depression/Anxiety |
5 (3.5) |
15 (11.0) |
0.01 |
|
Albumin |
4.1 (0.3) |
4.0 (0.4) |
0.02 |
|
Hemoglobin |
12.9 (1.6) |
12.0 (2.0) |
<0.01 |
|
Calcium |
9.8 (0.5) |
9.2 (0.9) |
<0.01 |
| Phosphorus | 3.3 (1.1) | 3.1 (0.8) | 0.08 |
Characteristics of study samples. * Fourteen subjects were returned to dialysis at the time of survey. * p values based on Χ2 or Student’s t-test.